Evidence map›Paper›PMID 33765066›Full record

ArticlePloS one2021

A549 cells contain enlarged mitochondria with independently functional clustered mtDNA nucleoids.

Aleksandrs Nasonovs, Miguel Garcia-Diaz, Daniel F Bogenhagen

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. LowerCancer genomics & proteomics
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Aleksandrs NasonovsDepartment of Pharmacological Sciences, Stony Brook University, Stony Brook, NY, United States of America.ORCID 0000-0001-7651-6669
Miguel Garcia-DiazDepartment of Pharmacological Sciences, Stony Brook University, Stony Brook, NY, United States of America.
Daniel F BogenhagenDepartment of Pharmacological Sciences, Stony Brook University, Stony Brook, NY, United States of America.ORCID 0000-0002-9993-2574
Stony Brook University · US

Funding

Training Program in Pharmacological SciencesT32GM007518 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI GARCIA-DIAZ, MIGUEL · 1985 to 2021
$5.4M
Mechanism of Mitochondrial Ribosome AssemblyR01GM112790 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI BOGENHAGEN, DANIEL F. · 2015 to 2018
$1.3M
Shared Instrumentation Grant for Purchase of a Nikon N-SIM/N-STORM Super-ResolutiS10OD016405 · OD · STATE UNIVERSITY NEW YORK STONY BROOK · PI TAKEMARU, KEN-ICHI · 2013 to 2013
$600k
Shared Instrumentation Grant for the purchase of a Leica SP8X ConfocalS10OD020096 · OD · STATE UNIVERSITY NEW YORK STONY BROOK · PI COLOGNATO, HOLLY A · 2016 to 2016
$580k
NIGMS NIH HHS R01 GM112790NIGMS NIH HHS T32 GM007518NIH HHS S10 OD016405NIH HHS S10 OD020096
6 · The paper itself

Abstract

Mitochondria are commonly viewed as highly elongated organelles with regularly spaced mtDNA genomes organized as compact nucleoids that generate the local transcripts essential for production of mitochondrial ribosomes and key components of the respiratory chain. In contrast, A549 human lung carcinoma cells frequently contain apparently swollen mitochondria harboring multiple discrete mtDNA nucleoids and RNA processing granules in a contiguous matrix compartment. While this seemingly aberrant mitochondrial morphology is akin to "mito-bulbs" previously described in cells exposed to a variety of genomic stressors, it occurs in A549 cells under typical culture conditions. We provide a detailed confocal and super-resolution microscopic investigation of the incidence of such mito-bulbs in A549 cells. Most mito-bulbs appear stable, engage in active replication and transcription, and maintain respiration but feature an elevated oxidative environment. High concentrations of glucose and/or L-glutamine in growth media promote a greater incidence of mito-bulbs. Furthermore, we demonstrate that treatment of A549 cells with TGFβ suppresses the formation of mito-bulbs while treatment with a specific TGFβ pathway inhibitor substantially increases incidence. This striking heterogeneity of mitochondrial form and function may play an important role in a variety of diseases involving mitochondrial dysfunction.

Indexed as

A549 CellsDNA, MitochondrialElectron Transport Complex IVGlucoseGlutamineHumansMembrane Potential, MitochondrialMicroscopy, ConfocalMitochondriaMitochondrial DynamicsMitochondrial MembranesRNATransforming Growth Factor betaDNA, MitochondrialElectron Transport Complex IVGlucoseGlutamineRNATransforming Growth Factor beta

Identifiers

PMID33765066
PMCPMC7993880
OpenAlexW3136335079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.